A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Clinical trial NCT04392648 · WITHDRAWN
Trial details
- NCT number
- NCT04392648
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-24
- Primary completion
- 2023-11-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.